AERIE PHARMACEUTICALS INC's ticker is AERI and the CUSIP is 00771V108. A total of 110 filers reported holding AERIE PHARMACEUTICALS INC in Q2 2015. The put-call ratio across all filers is 0.92 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $4,153,000 | +17.7% | 109,734 | +17.4% | 0.01% | +25.0% |
Q3 2016 | $3,528,000 | +113.9% | 93,490 | -0.2% | 0.00% | +100.0% |
Q2 2016 | $1,649,000 | +82.8% | 93,699 | +26.4% | 0.00% | +100.0% |
Q1 2016 | $902,000 | -49.4% | 74,148 | +1.3% | 0.00% | -50.0% |
Q4 2015 | $1,783,000 | +37.2% | 73,218 | -0.1% | 0.00% | 0.0% |
Q3 2015 | $1,300,000 | -0.2% | 73,265 | -0.8% | 0.00% | 0.0% |
Q2 2015 | $1,303,000 | +36.7% | 73,851 | +142.9% | 0.00% | +100.0% |
Q1 2015 | $953,000 | +8.9% | 30,401 | +1.5% | 0.00% | 0.0% |
Q4 2014 | $875,000 | +38.2% | 29,965 | -2.0% | 0.00% | 0.0% |
Q3 2014 | $633,000 | -15.3% | 30,576 | +1.3% | 0.00% | 0.0% |
Q2 2014 | $747,000 | +56.6% | 30,177 | +33.9% | 0.00% | 0.0% |
Q1 2014 | $477,000 | +34.7% | 22,533 | +14.2% | 0.00% | 0.0% |
Q4 2013 | $354,000 | – | 19,727 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Foresite Capital Management II, LLC | 1,464,749 | $98,944,000 | 34.86% |
Foresite Capital Management III, LLC | 1,708,046 | $115,379,000 | 24.85% |
Eversept Partners, LP | 226,902 | $15,327,230 | 7.01% |
SECTORAL ASSET MANAGEMENT INC | 615,870 | $41,602,000 | 4.65% |
DAFNA Capital Management LLC | 131,770 | $8,901,000 | 4.17% |
PACIFIC VIEW ASSET MANAGEMENT, LLC | 68,666 | $4,638,000 | 3.67% |
Asymmetry Capital Management, L.P. | 49,756 | $3,361,000 | 3.30% |
PFM Health Sciences, LP | 2,720,218 | $183,751,000 | 2.88% |
HealthCor Management, L.P. | 1,314,290 | $88,780,000 | 2.82% |
Boulegeris Investments, Inc. | 66,540 | $4,495,000 | 2.25% |